We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

44 hedge funds and large institutions have $80.6M invested in Avadel Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

174% more call options, than puts

Call options by funds: $655K | Put options by funds: $239K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

44% more capital invested

Capital invested by funds: $55.9M → $80.6M (+$24.7M)

0.06% more ownership

Funds ownership: 51.79% → 51.85% (+0.06%)

2% less funds holding

Funds holding: 45 → 44 (-1)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

Holders
44
Holders Change
-1
Holders Change %
-2.22%
% of All Funds
0.96%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
8
Increased
9
Reduced
10
Closed
9
Calls
$655K
Puts
$239K
Net Calls
+$416K
Net Calls Change
+$485K

Top Buyers

Rank Fund Capital Flow
1
GJL
Gendell Jeffrey L
+$926K
2
BCM
Brown Capital Management
Maryland
+$430K
3
PVI
Pura Vida Investments
New York
+$304K
4
Millennium Management
Millennium Management
New York
+$298K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$236K

Top Sellers

Rank Fund Capital Flow
1
BIP
Brandes Investment Partners
California
-$1.51M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$515K
3
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$137K
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$83.5K
5
CS
Credit Suisse
Switzerland
-$77.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIP
1
Brandes Investment Partners
California
$25.7M -$1.51M -601,954 -9%
BC
2
Broadfin Capital
New York
$12.9M – – –
DM
3
Deerfield Management
New York
$11.3M – – –
BCM
4
Brown Capital Management
Maryland
$7.06M +$430K +171,862 +11%
Renaissance Technologies
5
Renaissance Technologies
New York
$3.42M +$48.6K +19,400 +2%
TCM
6
Tekla Capital Management
Massachusetts
$3.39M – – –
Ameriprise
7
Ameriprise
Minnesota
$3.18M +$64.1K +25,600 +3%
Morgan Stanley
8
Morgan Stanley
New York
$3.08M +$56.6K +22,595 +3%
Deutsche Bank
9
Deutsche Bank
Germany
$2.45M -$3.43K -1,369 -0.2%
JAM
10
JW Asset Management
Florida
$1.85M – – –
GJL
11
Gendell Jeffrey L
$1.54M +$926K +369,726 New
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$802K +$236K +94,350 +96%
CIBC Private Wealth Group
13
CIBC Private Wealth Group
Georgia
$624K – – –
PVI
14
Pura Vida Investments
New York
$505K +$304K +121,435 New
Millennium Management
15
Millennium Management
New York
$494K +$298K +118,888 New
State Street
16
State Street
Massachusetts
$371K – – –
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$352K – – –
Geode Capital Management
18
Geode Capital Management
Massachusetts
$192K – – –
IAMOG
19
Investors Asset Management of Georgia
Georgia
$150K +$7.51K +3,000 +9%
EVM
20
Eaton Vance Management
Massachusetts
$134K -$6.42K -2,565 -7%
Walleye Trading
21
Walleye Trading
New York
$129K +$77.8K +31,078 New
Walleye Capital
22
Walleye Capital
New York
$128K +$77K +30,758 New
Citadel Advisors
23
Citadel Advisors
Florida
$107K -$15.9K -6,367 -20%
JP Morgan Chase
24
JP Morgan Chase
New York
$94K – – –
CS
25
Credit Suisse
Switzerland
$87K -$77.5K -30,968 -60%
1
2

AVDL Hedge Fund Activity: Q3 2019 in Review

44 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q3 2019, worth a combined $80.6M — up 44% from $55.9M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of AVDL and 8 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 9 added.

The largest buyer was Gendell Jeffrey L, opening a new position worth an estimated $926K. The largest seller was Brandes Investment Partners, cutting an estimated $1.51M.

  • 44 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q3 2019, down from 45 in Q2 2019.
  • Funds reported $80.6M of Avadel Pharmaceuticals stock for Q3 2019, up 44% quarter-over-quarter.
  • 8 funds opened new Avadel Pharmaceuticals positions in Q3 2019 and 9 closed out, a net change of -1 holder.
  • The largest Avadel Pharmaceuticals buyer in Q3 2019 was Gendell Jeffrey L, an estimated $926K added.
  • The largest Avadel Pharmaceuticals seller in Q3 2019 was Brandes Investment Partners, an estimated $1.51M sold.

Based on aggregated 13F filings for Q3 2019.